| Not Yet Recruiting | Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathologica NCT07404228 | Institut du Cancer de Montpellier - Val d'Aurelle | — |
| Not Yet Recruiting | Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC NCT07235306 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Not Yet Recruiting | Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC NCT07177794 | Sun Yat-sen University | Phase 3 |
| Recruiting | SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC NCT07198165 | Ruijin Hospital | Phase 2 |
| Recruiting | Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy NCT07205536 | Affiliated Hospital of Nantong University | Phase 2 |
| Recruiting | Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients NCT07086469 | Sun Yat-sen University | Phase 2 |
| Active Not Recruiting | A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients W NCT07091305 | Shanghai Chest Hospital | Phase 2 |
| Completed | US Radiomics in Advanced Cervical Cancer NCT06984289 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Not Yet Recruiting | Application of Intelligent Care Systems in Radiation Therapy: Enhancing Patient Safety and Reducing Anxiety Th NCT06833801 | Chung Shan Medical University | N/A |
| Recruiting | Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830 | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | Phase 2 / Phase 3 |
| Recruiting | Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small NCT06719700 | Sun Yat-sen University | Phase 2 |
| Recruiting | Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma NCT06413342 | Zhejiang Cancer Hospital | Phase 2 |
| Recruiting | Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Pati NCT07131670 | Qian Chu | — |
| Recruiting | Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy NCT06667622 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer NCT06421376 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Toripalimab Combined With Definitive CCRT for LACC Patients NCT06256224 | Ruijin Hospital | N/A |
| Recruiting | Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable NCT05833594 | Anhui Provincial Hospital | — |
| Recruiting | Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esoph NCT06190847 | Anhui Provincial Hospital | — |
| Unknown | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy NCT05620199 | The Netherlands Cancer Institute | N/A |
| Recruiting | Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients NCT06429839 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinom NCT06410651 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer NCT05735145 | Fourth Affiliated Hospital of Guangxi Medical University | Phase 3 |
| Unknown | Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a NCT05341206 | Chang Gung Memorial Hospital | Phase 2 |
| Unknown | PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer NCT05311566 | Lei Li | Phase 2 |
| Unknown | Prehabilitation in Rectal Cancer: During Neoadjuvant Therapy vs Preoperative NCT05286086 | Corporacion Parc Tauli | N/A |
| Not Yet Recruiting | Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM NCT05129774 | Qilu Hospital of Shandong University | N/A |
| Terminated | Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer NCT05161572 | Fudan University | Phase 2 |
| Unknown | Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer NCT04772001 | Zhongnan Hospital | N/A |
| Recruiting | Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Asse NCT07290972 | Tata Memorial Hospital | — |
| Recruiting | Nutritional Status and Clinical Outcomes in Patients With Common Malignancies(NCOM) NCT06219083 | Xiaoqin Luo | — |
| Unknown | Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer NCT05863260 | Fudan University | — |
| Unknown | Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize NCT05027165 | LMU Klinikum | — |
| Completed | Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer NCT04821765 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Active Not Recruiting | Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shan NCT04764227 | Fudan University | Phase 2 |
| Unknown | Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-ra NCT04741633 | Fudan University | — |
| Recruiting | Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Sh NCT04519905 | Fudan University | N/A |
| Completed | To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer P NCT04199832 | Tianjin Medical University Cancer Institute and Hospital | — |
| Unknown | Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer NCT04227886 | Fudan University | — |
| Completed | A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer NCT04207918 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | Chemoradiotherapy in Unresectable Esophageal Cancer NCT04278287 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 / Phase 2 |
| Unknown | Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ NCT04061928 | Peking University | Phase 1 / Phase 2 |
| Unknown | PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phas NCT05520814 | Sichuan Cancer Hospital and Research Institute | Phase 2 |
| Completed | A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients NCT05590650 | China Medical University Hospital | Phase 1 |
| Completed | Non-OpeRative MANagement of Rectal Cancer Patients NCT04696757 | Kangbuk Samsung Hospital | Phase 2 |
| Unknown | Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer NCT03286348 | Fudan University | — |
| Unknown | Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors NCT03177382 | West China Hospital | Phase 3 |
| Completed | Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma NCT02399306 | Sichuan Cancer Hospital and Research Institute | Phase 3 |
| Completed | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcin NCT02301481 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment NCT03623347 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma NCT00973778 | Shanghai Jiao Tong University School of Medicine | Phase 2 |